☰

Nick Pantaleo - Publications

Affiliations: 
2011-2012 New York University School of Medicine, New York, NY, United States 
Tree Info Grants Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Martin B, Chadwick W, Cong WN, Pantaleo N, Daimon CM, Golden EJ, Becker KG, Wood WH, Carlson OD, Egan JM, Maudsley S. Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy. The Journal of Biological Chemistry. 287: 31766-82. PMID 22822065 DOI: 10.1074/Jbc.M112.387316  0.485
2010 Cong WN, Golden E, Pantaleo N, White CM, Maudsley S, Martin B. Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction. Cns & Neurological Disorders Drug Targets. 9: 557-63. PMID 20632971 DOI: 10.2174/187152710793361513  0.569
2010 Pantaleo N, Chadwick W, Park SS, Wang L, Zhou Y, Martin B, Maudsley S. The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders. Cns & Neurological Disorders Drug Targets. 9: 627-35. PMID 20632965 DOI: 10.2174/187152710793361504  0.417
Show low-probability matches.